References
- Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: Assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009;19:35–42.
- Rosenthal DI, Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol. 2009;19:29–34.
- Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, et al. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res. 2004;10:1807–1812.
- Vissink A, Burlage FR, Spijkervet FK, Jansmal J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:213–225.
- Nagler RM, Baum BJ. Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch Otolaryngol Head Neck Surg. 2003;129:247–250.
- Russo G, Haddad R, Posner M, Mitchell M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist. 2008;13:886–898.
- Vijayalaxmi Reiter RJ, Tan DX, Herman TS, Thomas CR Jr. Melatonin as a radioprotective agent a review. Int J Radiat Oncol Biol Phys. 2004;59:639–653.
- Berndt C, Kurz T, Selenius M, Fernandes AP, Edgren MR, Brunk UT. Chelation of lysosomal iron protects against ionizing radiation. Biochem J. 2010;432:295–301.
- Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688–694.
- Qian L, Cao F, Cui J, Huang Y, Zhou X, Liu S, et al. Radioprotective effect of hydrogen in cultured cells and mice. Free Radic Res. 2010;44:275–282.
- Qian L, Cao F, Cui J, Wang Y, Huang Y, Chuai Y, et al. The potential cardioprotective effects of hydrogen in irradiated mice. J Radiat Res. 2010;51:741–747.
- Chuai Y, Gao F, Cai J. Hydrogen-rich saline attenuates radiation-induced male germ cell loss in mice through reducing hydroxyl radicals. Biochem J. 2012;442:49–56.
- Yu P, Wang Z, Sun X, Chen X, Zeng S, et al. Hydrogen-rich medium protects human skin fibroblasts from high glucose or mannitol induced oxidative damage. Biochem Biophys Res Commun. 2011;409:350–355.
- Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase(SOD). Indian J Biochem Biophys. 1984;21:130–132.
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
- Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52:61–77; viii.
- Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res. 2007;48:263–272.
- Yan SX, Hong XY, Hu Y, Liao KH. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts. J. Dermatol Sci. 2005;37:137–143.
- Qian L, Cao F, Cui J, Huang Y, Zhou X, Liu S, et al. Radioprotective effect of hydrogen in cultured cells and mice. Free Radic Res. 2010;44:275–282.
- Kalpana KB, Devipriya N, Srinivasan M. Investigation of the radioprotective efficacy of hesperidin against gamma-radiation induced cellular damage in cultured human peripheral blood lymphocytes. Mutat Res. 2009;676:54–61.
- El-Nahas SM, Mattar RE, Mohamed AA. Radioprotective effect of vitamins C and E. Mutat Res. 1993;301:143.
- Pandey BN, Mishra KP. Fluorescence and ESR studies on membrane oxidative damage by γ-radiation. Appl Magn Reson. 2000;18:483–492.
- Gosselin TK, Mautner B. Amifostine as a radioprotectant. Clin J Oncol Nurs. 2002;6:175–176; 180.
- Brizel DM. Pharmacologic approaches to radiation protection. J Clin Oncol. 2007;25:4084–4089.
- Grdina DJ, Murley JS, Kataoka Y, Baker KL, Kunnavakkam R, Coleman MC, et al. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009;73:886–896.
- Herodin F, Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol. 2005;33:1071–1108.
- Hosseinimehr SJ. Trends in the development of radioprotective agents. Drug Discov Today. 2007;12:794–805.
- Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002;3:1129–1134.
- Labiche LA, Grotta JC. Clinical trials for cytoprotection in stroke. NeuroRx. 2004;1:46–70.
- McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22:163–173.